Vir Biotechnology to Present at 40th Annual Cowen Healthcare Conference

NEXT STORY
Excel Nuclear Oncology Center initiates the first Lu-177 DOTATOC PRRT clinical trial for the PUT-Neuroendocrine Tumors, in U.S.
PREV STORY
Black Diamond Therapeutics to Present at the Cowen and Company 40th Annual Health Care Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Beyond Air® to Present Posters on CoronaVirus and Bronchiolitis at the CHEST 2020 Annual Meeting

author_avatar
NASDAQ Market News

Arch Oncology to Collaborate with Merck on Phase 1/2 Clinical Trial of Anti-CD47 Antibody AO-176 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Select Solid Tumors

author_avatar
NASDAQ Market News

Insights on the AI-based Clinical Trials Solution Provider Global Market to 2028 – by Therapeutic Application, Clinical Trial Phase, End-user and Region

author_avatar
NASDAQ Market News